Scott WilliamsNuclear MedicineTumor ImagingOncoScint (Satumomab Pendetide):Scott WilliamsApr 2, 2002OncoScint (Satumomab Pendetide): General: Chemistry and Pharmacology Distribution Indications for the Oncoscint exam Colorectal carcinoma: Recurrent Disease Liver Mets Extrahepatic Abdominal Mets Ovarian Carcinoma Complications/Side Effects: General HAMA Formation Latest in Tumor ImagingTumor > Therapy > Xofigo and other Prostate AgentsAugust 16, 2017Tumor > Therapy > Xofigo and PSMA therapiesJanuary 26, 2015SponsoredRegister Now: Breaking Barriers in Breast Imaging WebinarOctober 7, 2025Tumor > Therapy > MicrospheresJanuary 31, 2008Related StoriesNuclear MedicineProstascint (111In-Capromab Pendetide) (CYT-356)Nuclear MedicineTc-99m-Arcitumomab (CEA-Scan)Tumor ImagingThallium Tumor Imaging:Sponsor ContentRegister Now: Breaking Barriers in Breast Imaging Webinar